Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Olin Corporation reported its second quarter 2026 results amid a complex global environment marked by geopolitical tensions and fluctuating supply-demand dynamics.</li><li>A significant development was the announcement of Olin’s planned merger with Huntsman Corporation, aiming to create a vertically integrated, North American-focused chemical leader with over $12 billion in sales.</li><li>The company has made progress toward this transaction, including proxy filings and shareholder engagements, with expected merger synergies of $400 million anticipated in the first half of 2027.</li></ul>

Olin Corporation reported its second quarter 2026 results amid a complex global environment marked by geopolitical tensions and fluctuating supply-demand dynamics.A significant development was the announcement of Olin’s planned merger with Huntsman Corporation, aiming to create a vertically integrated, North American-focused chemical leader with over $12 billion in sales.The company has made progress toward this transaction, including proxy filings and shareholder engagements, with expected merger synergies of $400 million anticipated in the first half of 2027.

Olin Corporation Unlocks A Larger North American Chemicals Platform With Huntsman!

<ul><li>Olin Corporation has entered one of the most important strategic moves in its recent history by agreeing to combine with Huntsman Corporation (NYSE:HUN) in an all-stock transaction that would create OlinHuntsman, a North American chemicals company with roughly $12.5 billion in annual revenue.</li><li>The proposed structure gives Olin shareholders about 54.5% of the combined company and Huntsman investors about 45.5%, with closing targeted for the first half of 2027, subject to shareholder and regulatory approvals.</li><li>The headline controversy is that Huntsman accepted terms that appeared to value it at about $13.85 per share, roughly 13% below its prior close.</li></ul>

Olin Corporation has entered one of the most important strategic moves in its recent history by agreeing to combine with Huntsman Corporation (NYSE:HUN) in an all-stock transaction that would create OlinHuntsman, a North American chemicals company with roughly $12.5 billion in annual revenue.The proposed structure gives Olin shareholders about 54.5% of the combined company and Huntsman investors about 45.5%, with closing targeted for the first half of 2027, subject to shareholder and regulatory approvals.The headline controversy is that Huntsman accepted terms that appeared to value it at about $13.85 per share, roughly 13% below its prior close.

Olin Acquisition Drama: The $12.5 Billion Chemicals Shake-Up!

<ul><li>Olin Corporation's fourth-quarter 2025 results reflect a complex interplay of operational challenges, macroeconomic pressures, and strategic actions aimed at navigating a difficult market environment.</li><li>During the quarter, Olin faced significant operational issues, including an extended turnaround at its Freeport, Texas chlorinated organics asset and raw material supply constraints, exacerbating the typically weak demand seen in the seasonally softer fourth quarter.</li><li>Additionally, a sharp decline in chlorine pipeline demand further impacted results.</li></ul>

Olin Corporation's fourth-quarter 2025 results reflect a complex interplay of operational challenges, macroeconomic pressures, and strategic actions aimed at navigating a difficult market environment.During the quarter, Olin faced significant operational issues, including an extended turnaround at its Freeport, Texas chlorinated organics asset and raw material supply constraints, exacerbating the typically weak demand seen in the seasonally softer fourth quarter.Additionally, a sharp decline in chlorine pipeline demand further impacted results.

Olin Corporation: How the Lake City Project Is Reshaping Its Earnings Profile?

Credit

<ul><li>Olin Corporation delivered mixed third quarter 2025 results that reflected resilience in its core chlor alkali value chain alongside continued pressure in downstream and consumer-exposed areas.</li><li>The investment thesis remains centered on disciplined value-first commercial execution, working capital release, and incremental self-help initiatives that can stabilize performance while the company preserves leverage to an eventual demand recovery.</li><li>Offsetting this, management indicated that end-market conditions are not yet improving across several businesses, and near-term profitability is being intentionally reduced to reset inventories and protect pricing discipline.</li></ul>

Olin Corporation delivered mixed third quarter 2025 results that reflected resilience in its core chlor alkali value chain alongside continued pressure in downstream and consumer-exposed areas.The investment thesis remains centered on disciplined value-first commercial execution, working capital release, and incremental self-help initiatives that can stabilize performance while the company preserves leverage to an eventual demand recovery.Offsetting this, management indicated that end-market conditions are not yet improving across several businesses, and near-term profitability is being intentionally reduced to reset inventories and protect pricing discipline.

Olin Corporation Lands a Critical Clean Hydrogen Win With the 45V Tax Credit Boost!

Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

<ul>
  <li>
<a href="https://smartkarma.com/entities/olin-corp">Olin Corp</a>. is a leading, vertically integrated global manufacturer of chemical products and ammunition, operating through its Chlor Alkali Products and Vinyls, Epoxy, and Winchester segments.</li>
  <li>The company is navigating a challenging petrochemical environment by focusing on a U.S.-centric sales strategy and prioritizing cash generation and shareholder returns, which has allowed it to outperform peers.</li>
  <li>Financial performance has been under pressure, with declining revenue and net income over the past three years, reflecting weak demand, low prices, and higher input costs in the broader chemical sector.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  
Olin Corp. is a leading, vertically integrated global manufacturer of chemical products and ammunition, operating through its Chlor Alkali Products and Vinyls, Epoxy, and Winchester segments.
  The company is navigating a challenging petrochemical environment by focusing on a U.S.-centric sales strategy and prioritizing cash generation and shareholder returns, which has allowed it to outperform peers.
  Financial performance has been under pressure, with declining revenue and net income over the past three years, reflecting weak demand, low prices, and higher input costs in the broader chemical sector.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

United States

Olin Corporation manufactures chemicals and ammunition products. The Company manufactures and sells chlorine, caustic soda, sodium hydrosulfite, hydrochloric acid, hydrogen, sodium chlorate, bleach products, and potassium hydroxide. Olin also manufactures products that include sporting ammunition, reloading components, small caliber military ammunition and industrial cartridges.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Olin Corp (OLN US)

Olin Corporation Unlocks A Larger North American Chemicals Platform With Huntsman!

Olin Corporation reported its second quarter 2026 results amid a complex global environment marked by geopolitical tensions and fluctuating...

Baptista Research

Olin Acquisition Drama: The $12.5 Billion Chemicals Shake-Up!

Olin Corporation has entered one of the most important strategic moves in its recent history by agreeing to combine with Huntsman Corporation...

Baptista Research

Olin Corporation: How the Lake City Project Is Reshaping Its Earnings Profile?

Olin Corporation's fourth-quarter 2025 results reflect a complex interplay of operational challenges, macroeconomic pressures, and strategic...

Baptista Research

Olin Corporation Lands a Critical Clean Hydrogen Win With the 45V Tax Credit Boost!

Olin Corporation delivered mixed third quarter 2025 results that reflected resilience in its core chlor alkali value chain alongside continued...

Baptista Research

Primer: Olin Corp (OLN US) - Dec 2025

Olin Corp. is a leading, vertically integrated global manufacturer of chemical products and ammunition, operating through its Chlor Alkali...

αSK Primers

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)